Concord Drugs Ltd Financial Statement
*All values are in Rs. Cr
Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
---|---|---|---|
Revenue | 13.38 | 7.97 | 10.77 |
Operating Expense | 12.45 | 7.04 | 9.46 |
Net Profit | 0.11 | 0.01 | 0.22 |
Net Profit Margin | 0.82 | 0.13 | 2.04 |
Earning Per Share | 0.11 | 0.01 | 0.22 |
EBIDTA | 0.95 | 0.90 | 1.16 |
Effective Tax Rate | 5.32 | -1.08 | 10.69 |
Particulars | Jun 2025 |
---|---|
Revenue | 13.38 |
Operating Expense | 12.45 |
Net Profit | 0.11 |
Net Profit Margin | 0.82 |
Earning Per Share | 0.11 |
EBIDTA | 0.95 |
Effective Tax Rate | 5.32 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Total Revenue Annual | 36.93 | 43.26 | 51.31 |
Operating Expenses Annual | 33.17 | 39.58 | 46.97 |
Operating Profit Annual | 3.78 | 3.69 | 4.35 |
Interest Annual | 1.72 | 1.59 | 1.62 |
Depreciation | 1.42 | 1.54 | 1.60 |
Net Profit Annual | 0.30 | 0.42 | 0.89 |
Tax Annual | 0.35 | 0.14 | 0.23 |
Particulars | Mar 2025 |
---|---|
Total Revenue Annual | 36.93 |
Operating Expenses Annual | 33.17 |
Operating Profit Annual | 3.78 |
Interest Annual | 1.72 |
Depreciation | 1.42 |
Net Profit Annual | 0.30 |
Tax Annual | 0.35 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Cash Flow at the Beginning | 0.14 | 0.08 | 0.04 |
Cash Flow from Operations | 3.16 | 1.96 | 2.24 |
Cash Flow from Investing | -2.32 | -1.21 | -2.27 |
Cash Flow from Financing | -0.87 | -0.69 | 0.05 |
Cash Flow at the End | 0.12 | 0.14 | 0.08 |
Particulars | Mar 2025 |
---|---|
Cash Flow at the Beginning | 0.14 |
Cash Flow from Operations | 3.16 |
Cash Flow from Investing | -2.32 |
Cash Flow from Financing | -0.87 |
Cash Flow at the End | 0.12 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
PBDIT Margin (%) | 10.24 | 8.53 | 8.48 |
PBIT Margin (%) | 6.39 | 4.97 | 5.36 |
PBT Margin (%) | 2.65 | 1.85 | 2.07 |
Net PROFIT Margin (%) | 0.81 | 0.97 | 1.73 |
Return On Networth / Equity (%) | 0.88 | 1.28 | 2.96 |
Return On Networth /Employed (%) | 4.49 | 4.24 | 5.67 |
Return On Assets (%) | 0.57 | 0.83 | 1.84 |
Total Debt / Equity (X) | 0.47 | 0.47 | 0.53 |
Asset Turnover Ratio (%) | 0.70 | 0.85 | 1.06 |
Particulars | Mar 2025 |
---|---|
PBDIT Margin (%) | 10.24 |
PBIT Margin (%) | 6.39 |
PBT Margin (%) | 2.65 |
Net PROFIT Margin (%) | 0.81 |
Return On Networth / Equity (%) | 0.88 |
Return On Networth /Employed (%) | 4.49 |
Return On Assets (%) | 0.57 |
Total Debt / Equity (X) | 0.47 |
Asset Turnover Ratio (%) | 0.70 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Fixed Assets Annual | 11.54 | 10.99 | 12.22 |
Total Current Assets Annual | 33.42 | 34.28 | 41.40 |
Non Current Assets Annual | 25.16 | 22.01 | 15.23 |
Total Shareholders Funds Annual | 34.11 | 33.82 | 31.70 |
Total Assets Annual | 58.58 | 56.30 | 56.63 |
Particulars | Mar 2025 |
---|---|
Fixed Assets Annual | 11.54 |
Total Current Assets Annual | 33.42 |
Non Current Assets Annual | 25.16 |
Total Shareholders Funds Annual | 34.11 |
Total Assets Annual | 58.58 |
EPS (INR)
Expected
0.12
Reported
0.12
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%